Mohammad Amin Vatankhah

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Benign Prostatic Hyperplasia

Small Cell Lung Cancer

Top Venues

Asian Pacific journal of cancer prevention : APJCP

This page only lists publications with an associated author ORCID identifier.

Publications

Alireza Anvarnia, Reza Panahizadeh, Habib Zarredar, Milad Asadi, Shahriyar Hashemzadeh, Mohammad Amin Vatankhah, Hamed Valizadeh, Mortaza Raeisi
Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 24 (4) (2023)
Alireza Anvarnia, Reza Panahizadeh, Habib Zarredar, Milad Asadi, Shahriyar Hashemzadeh, Mohammad Amin Vatankhah, Hamed Valizadeh, Mortaza Raeisi
Down-regulation and Clinic-pathological Correlation of SIK-1 and SIK-1-LNC in Non-small Cell Lung Cancer Patients Asian Pacific journal of cancer prevention : APJCP 24 (4) (2023)
Alireza Anvarnia, Reza Panahizadeh, Habib Zarredar, Milad Asadi, Shahriyar Hashemzadeh, Mohammad Amin Vatankhah, Hamed Valizadeh, Mortaza Raeisi
Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 24 (4) (2023)
Alireza Anvarnia, Reza Panahizadeh, Habib Zarredar, Milad Asadi, Shahriyar Hashemzadeh, Mohammad Amin Vatankhah, Hamed Valizadeh, Mortaza Raeisi
Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 24 (4) (2023)
Mohammad Amin Vatankhah, Reza Panahizadeh, Kazem Nejati-Koshki, Mahsa Arabzadeh, Amir Ahmad Arabzadeh, Najafzadeh Nowruz
Curcumin Upregulates miR-148a to Increase the Chemosensitivity of CD44-Positive Prostate Cancer Stem Cells to Paclitaxel Through Targeting the MSK1/IRS1 axis. Drug research 72 (8) (2022)
Parya Khakbaz, Reza Panahizadeh, Mohammad Amin Vatankhah, Najafzadeh Nowruz
Allicin Reduces 5-fluorouracil-resistance in Gastric Cancer Cells through Modulating MDR1, DKK1, and WNT5A Expression. Drug research 71 (8) (2021)